API & Bulk Drugs
Active ingredients and intermediates
Long multi-stage campaigns, solvent recovery, and a cost structure where yield is the whole margin. API plants need reaction-stage tracking and recovery accounting that formulation systems do not have.
What this configuration adds
- Multi-stage synthesis with intermediate isolation and hold-time control
- Solvent and mother liquor recovery, credited back to batch cost
- Reaction parameter capture from the plant where interfaces exist
- Campaign planning with changeover and cleaning validation constraints
- Residual solvent and impurity profiling in the LIMS
The same core underneath
Every industry configuration is the same fifteen modules, the same audit trail and the same validation approach. What changes is the masters, the batch record structure and the records that segment is inspected against.
That means you are not buying a bespoke system. You are buying a proven one with your segment's requirements already built into it — which is why a rollout takes months rather than years.
Core modules in this configuration
All fifteen are available. These are the ones a api & bulk drugs operation usually starts with.
See it on your own floor.
Two hours with your production and QA leads. We walk one product end to end and show you where it lands in the system — then you decide whether a gap study is worth it.